Document:

EX-10.12

 Exhibit 10.12 

 
  
  

 
  
  

 
  
  

 
  
  

PROTHENA BIOSCIENCES INC 

AMENDED AND RESTATED 

SEVERANCE PLAN 

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
	 ARTICLE I INTRODUCTION
	  	 	1	  
		
	 ARTICLE II DEFINITIONS
	  	 	1	  
		
	 ARTICLE III ELIGIBILITY
	  	 	5	  
		
	 ARTICLE IV PAY AND BENEFITS IN LIEU
OF WARN NOTICE
	  	 	7	  
		
	 ARTICLE V SEVERANCE PAY AND SEVERANCE
BENEFITS
	  	 	7	  
		
	 ARTICLE VI WAIVER AND RELEASE AGREEMENT
	  	 	10	  
		
	 ARTICLE VII PLAN ADMINISTRATION
	  	 	11	  
		
	 ARTICLE VIII PROCEDURES FOR MAKING AND
APPEALING CLAIMS FOR PLAN BENEFITS
	  	 	12	  
		
	 ARTICLE IX AMENDMENT/TERMINATION/VESTING
	  	 	13	  
		
	 ARTICLE X NO ASSIGNMENT
	  	 	13	  
		
	 ARTICLE XI CONFIDENTIAL INFORMATION/COOPERATION
	  	 	14	  
		
	 ARTICLE XII MISCELLANEOUS PROVISIONS
	  	 	14	  

 PROTHENA BIOSCIENCES INC 

SEVERANCE PLAN 
 ARTICLE I 
 INTRODUCTION 

Effective as of the Original Effective Date, the Company adopted this Plan for the benefit of certain “Eligible Employees” of
the Company and certain Affiliates specified by the Company who were then employed by the Company. The Company hereby amends and restates the Plan, effective as of the Amendment and Restatement Effective Date, for the benefit of Eligible Employees
hired after the Original Effective Date and, effective as of January 1, 2014, for the benefit of all Eligible Employees, including Eligible Employees employed on the Original Effective Date. The Plan is intended to apply to United States based
“Employees,” as described herein. The Plan shall be binding on any successor to all or substantially all of the Company’s assets or business. 
 The Plan is an unfunded welfare benefit plan for purposes of the ERISA. Except as otherwise provided herein, the Plan supersedes any prior formal or informal severance plans, programs or policies of the
Company or its Affiliates covering Eligible Employees. The Plan operates on a calendar year. 
 ARTICLE II

 DEFINITIONS 
 2.1. “Act” means the Irish Companies Act 1963, as amended from time to time. References to any provision of the Act shall be deemed to include successor provisions thereto and regulations
thereunder. 
 2.2. “Affiliate” means any member of the group of corporations, trades or businesses or other
organizations comprising the “controlled group” with the Company under Code Section 414. 
 2.3.
“Amendment and Restatement Effective Date” means March 4, 2013. 
 2.4. “Base
Compensation” means an Eligible Employee’s rate of base compensation as of the Eligible Employee’s Severance Date (and prior to any reduction due to a Significant Reduction in Scope or Base Compensation, if applicable).

 2.5. “Change in Control” means: 

 

	 	(a)	 The consummation of a merger or consolidation of Prothena Corporation plc with or into another entity or any other corporate reorganization (however
effected, including by general offer or court sanctioned compromise, arrangement or scheme under the Act or otherwise), if more than fifty percent (50%) of the 

	 	
combined voting power of the continuing or surviving entity’s issued shares or securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons
who were not shareholders of Prothena Corporation plc immediately prior to such merger, consolidation or other reorganization; 

  

	 	(b)	The sale, transfer or other disposition of all or substantially all of Prothena Corporation plc’s assets; 

 

	 	(c)	Individuals who, as of the date that the Board of Directors of Prothena Corporation plc first consists of at least seven members, constitute the Board of Directors of
Prothena Corporation plc (the “Incumbent Directors”) cease for any reason, including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to constitute at least a majority of the Board of
Directors of Prothena Corporation plc; provided, however, that any individual who becomes a director of Prothena Corporation plc subsequent to the date that the Board of Directors of Prothena Corporation plc first consists of at least seven members
shall be considered an Incumbent Director if such person’s election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors; but, provided further that any such person whose initial assumption of
office is in connection with an actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of Prothena Corporation plc, including by reason of agreement intended to avoid or settle any such
actual or threatened contest or solicitation, shall not be considered an Incumbent Director; 

  

	 	(d)	A transaction as a result of which a person or company obtains the ownership directly or indirectly of the ordinary shares in Prothena Corporation plc carrying more
than fifty percent (50%) of the total voting power represented by Prothena Corporation plc’s issued share capital in pursuance of a compromise or arrangement sanctioned by the court under section 201 of the Act or becomes bound or entitled
to acquire ordinary shares in Prothena Corporation plc under section 204 of the Act; or 

  

	 	(e)	Any transaction as a result of which any person becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of
securities of Prothena Corporation plc representing at least fifty percent (50%) of the total voting power represented by Prothena Corporation plc’s then outstanding voting securities (e.g., issued shares). For purposes of this subsection
(e), the term “person” shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude (i) a trustee or other fiduciary holding securities under an employee benefit plan of Prothena
Corporation plc or of any subsidiary of Prothena Corporation plc and (ii) a company owned directly or indirectly by the shareholders of Prothena Corporation plc in substantially the same proportions as their ownership of the ordinary shares of
Prothena Corporation plc. 

  
 2 

	 	(f)	Notwithstanding the foregoing, in the case of any amounts payable under the Plan that constitute deferred compensation subject to Code Section 409A, the definition
of “Change in Control” set forth above shall not apply, and the term “Change in Control” shall instead mean a “change in the ownership or effective control” of Prothena Corporation plc or “in the ownership of a
substantial portion of the assets” of Prothena Corporation plc within the meaning of Code Section 409A(a)(2)(A)(v) and the regulations and guidance issued thereunder, but only to the extent this substitute definition is necessary in order
for the payments to comply with the requirements prescribed by Code Section 409A. 

 2.6.
“Code” means the Internal Revenue Code of 1986, as amended. 
 2.7. “Company” means Prothena
Biosciences Inc. 
 2.8. “Comparable Position” means a position either with the Company or any of its
Affiliates or with a successor or transferee of all or a part of the business of the Company or Affiliate, on terms which do not cause a Significant Reduction in Scope or Base Compensation and do not entail a Relocation. The Plan Administrator, in
its sole discretion, will determine whether a position is a Comparable Position. 
 2.9. “Confidential
Information” means trade secrets and other propriety information of an Employer or any Affiliate. If an Eligible Employee entered into a separate confidentiality or proprietary rights agreement with an Employer or any Affiliate, the term
“Confidential Information” for purposes of this Plan shall have the meaning ascribed to any such term or concept as it is defined under, or used in, the separate agreement. 

2.10. “Eligible Employee” means each Employee who is hired by an Employer after the Original Effective Date or,
beginning January 1, 2014, was employed by an Employer as of the Original Effective Date, and, in either case, who is not (i) covered by a written employment agreement that contains a severance provision, or covered by a written severance
agreement (for the duration of that agreement); (ii) classified as “temporary,” including without limitation, anyone classified as an “intern” or “co-op”; (iii) a consultant; (iv) a “leased
employee” as defined in Code Section 414(n); or (v) a person performing services for an Employer on a contract basis or as an independent contractor or consultant or through a purchase order, supplier agreement or any other form of
agreement that the Employer enters into for services, regardless of whether any of the above such individuals set forth in (iii), (iv) or (v) are subsequently determined by the Internal Revenue Service, the U.S. Department of Labor or a
court to be Employees. 
 2.11. “Employee” means any full-time or part-time employee of an Employer who
regularly works thirty (30) hours or more per calendar week for the Employer. 
 2.12. “Employer” means
the Company and each Affiliate identified on Attachment A, including the wholly-owned subsidiaries of the Affiliates identified on Attachment A. 

  
 3 

 2.13. “ERISA” means the Employee Retirement Income Security Act of 1974, as
amended. 
 2.14. “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

2.15. “Involuntary Termination” means a termination of an Eligible Employee’s employment by the Employer due to a
business condition, as determined in the sole discretion of the Employer. The term Involuntary Termination shall include (i) a termination effective when the Eligible Employee exhausts a leave of absence during, or at the end of, a WARN Notice
Period and (ii) a situation where an Eligible Employee on an approved leave of absence during which the Employee’s position is protected under applicable law (e.g., a leave under the Family Medical Leave Act), returns from such leave, and
cannot be placed in employment with the Employer. 
 2.16. “Original Effective Date” means December 21,
2012, the date that the separation of Prothena Corporation plc from Elan Corporation plc was first effective. 
 2.17.
“Plan” means the Prothena Biosciences Inc Severance Plan, as set forth in this instrument and as hereafter amended. 
 2.18. “Relocation” means a material change in the geographic location at which the Eligible Employee is required to perform services. Such change in an Eligible Employee’s primary
job site will be considered material if (i) for Eligible Employees other than field-based sales representatives (or similar field-based positions), the new location increases the Eligible Employee’s commute between home and primary job
site by at least thirty (30) miles, or (ii) in the Company’s reasonable opinion, the new location requires that the Eligible Employee move his/her home to a new location at least thirty (30) miles away from the Eligible
Employee’s home immediately prior to the change. 
 2.19. “Severance Date” means the final day of
employment with the Employer which date shall be communicated in writing by the Employer to the Employee. 
 2.20.
“Significant Reduction in Scope or Base Compensation” means a material diminution in the Eligible Employee’s authority, duties, or responsibilities or a material diminution in the Eligible Employee’s base compensation. The
Plan Administrator, in its sole discretion, shall determine whether an Eligible Employee experiences a “Significant Reduction.” 
 2.21. “Target Bonus” means an Eligible Employee’s target annual bonus rate during the year in which the Eligible Employee’s Severance Date occurs. 

2.22. “Triggering Event” means an Involuntary Termination, Relocation or Significant Reduction in Scope or Base
Compensation. 
 2.23. “WARN Notice Date” means the date the Employer is required to notify an Eligible
Employee pursuant to the WARN Act or similar state law that he/she is to be terminated from employment with the Employer in conjunction with a “plant closing” or “mass layoff” as described in the WARN Act or similar state law.

  
 4 

 2.24. “WARN Notice Period” means the sixty (60) consecutive calendar
day period, or other applicable period under similar state law, commencing on an Eligible Employee’s WARN Notice Date. 

2.25. “Week of Pay” shall be determined based on the Eligible Employee’s status as a salaried or hourly Employee.
If the Eligible Employee is a salaried Employee, Week of Pay shall be the Eligible Employee’s weekly Base Compensation. If the Eligible Employee is an hourly Employee, Week of Pay shall be the Eligible Employee’s hourly Base Compensation
multiplied by his/her regularly scheduled number of hours worked per week in effect on the Eligible Employee’s Severance Date. If the Eligible Employee works part-time, his/her Week of Pay is determined on a prorated basis by calculating
his/her average number of hours per week actually worked during the prior Year of Service. 
 2.26. “Years of
Service” shall be determined in accordance with the Employer’s personnel records. An Eligible Employee shall receive credit for a Year of Service for each twelve (12) month period of active service with the Employer. For partial
years of employment, the Eligible Employee shall receive credit for a full Year of Service if he/she completes at least six (6) full months of active service. If an Eligible Employee has not completed at least six (6) full months of active
service during a partial year, he/she shall not receive credit for a Year of Service. 
 ARTICLE III 

ELIGIBILITY 
 3.1. Conditions of Eligibility. To be eligible for benefits as described in Article V, the Eligible Employee must (i) remain an Employee through the Severance Date, (ii) through the
Severance Date, fulfill the normal responsibilities of his/her position, including meeting regular attendance, workload and other standards of the Employer, as applicable, and (iii) submit the signed Waiver and Release Agreement required by the
Plan Administrator on, or within forty-five (45) days after, his/her Severance Date or receipt of the Waiver and Release Agreement (whichever occurs later) and not revoke the signed Waiver and Release Agreement. In addition, in the event of a
Relocation or a Significant Reduction in Scope or Base Compensation, the Eligible Employee must provide his/her Employer with written notice within ninety (90) days after the occurrence of such event. The Employer shall then have thirty
(30) days to cure such event. 
 3.2. Conditions of Ineligibility. An otherwise Eligible Employee shall not receive
severance pay or severance benefits under the Plan if: 
  

	 	(a)	the Employee ceases to be an Eligible Employee as defined by the Plan; 

  

	 	(b)	the Employee terminates employment with the Employer by reason of death; 

  
 5 

	 	(c)	the Employer terminates the Employee’s employment for one or more of the following reasons (determined in the sole discretion of the Plan Administrator):
Commission by the Employee of an act of fraud, theft, misappropriation of funds, dishonesty, bad faith or disloyalty; violation by the Employee of any federal, state, local law or regulation; violation by the Employee of any rule, regulation or
policy of the Employer or other job related misconduct; failure to perform the duties of the position held by such Employee in a manner which satisfies the reasonable expectations of the Employer; failure by the Employee to meet any requirement
reasonably imposed upon such Employee by the Employer as a condition of continued employment; or dereliction or neglect by the Employee in the performance of such Employee’s job duties; 

 

	 	(d)	the Employee terminates employment with the Employer through job abandonment; 

 

	 	(e)	other than as set forth in Section 2.14(ii), the individual is no longer an Employee and is receiving long-term disability benefits from the Employer (as
determined under the applicable Employer-sponsored long-term disability plan) as of the date the Triggering Event would have occurred had the individual been an Employee on such date; 

 

	 	(f)	the Employee is employed in an operation, division, department or facility, that is sold, leased or otherwise transferred, in whole or in part, from an Employer, and
(i) the Employee accepts any position with the new owner/operator, or (ii) the Employee is offered a Comparable Position by the new owner/operator; 

 

	 	(g)	the Employee gives notice of his/her voluntary termination (other than as provided in Section 2.19) prior to his/her Severance Date or the effective date of a
sale, lease or transfer of an operation, division, department or facility, as described in Section 3.2(f), regardless of the effective date of such termination; 

 

	 	(h)	the Employee ceases working with the Employer and receives severance benefits under the terms of another group reorganization/restructuring benefit plan or severance
program sponsored by the Employer; 

  

	 	(i)	the Employee is offered a Comparable Position from an Employer, or accepts any position with an Employer, even if it is not a Comparable Position;

  

	 	(j)	the Employee experiences a Triggering Event after the Plan is terminated; 

  

	 	(k)	the Employee does not timely execute and return to the Plan Administrator a valid Waiver and Release Agreement; 

 

	 	(l)	the Employee works primarily in an office located in a country other than the United States and is entitled to severance benefits under the laws of such country or the
policies of the company at which he/she is based and such severance benefits may not be waived; or 

  
 6 

	 	(m)	the Employee is offered a Comparable Position by, or accepts any position with, an employer with which the Company or any of its Affiliates has reached an agreement or
arrangement under which the employer agrees to offer employment to the otherwise Eligible Employee. 

 The
foregoing list of conditions is intended to be illustrative and may not be all inclusive; the Plan Administrator will determine in the Plan Administrator’s sole discretion whether an Eligible Employee is eligible for severance pay and severance
benefits under the Plan. 
 3.3. CEO Eligibility. Notwithstanding anything to the contrary herein, the terms herein do
not modify the terms of the employment agreement between the Chief Executive Officer and the Company, dated January 22, 2013, as it may be amended from time to time (the “Employment Agreement”), except that a qualifying
termination that occurs within the twenty-four (24) month period commencing on the consummation of a Change in Control (as defined in the Employment Agreement), rather than the twelve (12) month period provided for in the Employment
Agreement, shall be considered a qualifying termination in connection with a Change in Control for purposes of Section 5(c) of the Employment Agreement. 
 ARTICLE IV 
 PAY AND
BENEFITS IN LIEU OF WARN NOTICE 
 4.1. Wage
Payments. If an Eligible Employee is entitled to advance notice of a “plant closing” or a “mass layoff” under the WARN Act or similar state law, but experiences a Triggering Event before the end of a WARN Notice Period, the
Eligible Employee shall be entitled to receive Weeks of Pay until the end of the WARN Notice Period as if he/she were still employed through such date. The Weeks of Pay under this Section 4.1 will be issued according to the normal payroll
practices of the Employer and shall not be subject to the Waiver and Release Agreement. 
 4.2. Benefits. An Eligible
Employee described in Section 4.1 shall be entitled to benefits under an Employer-sponsored medical, dental and vision benefit plans, as amended from time to time, through the end of the WARN Notice Period on the same terms and under the same
conditions as applied to the Eligible Employee immediately prior to the Triggering Event. The benefits under this Section 4.2 are not subject to the Waiver and Release Agreement. 

ARTICLE V 
 SEVERANCE PAY AND SEVERANCE BENEFITS 
 5.1. Generally. In exchange for providing the Employer with an enforceable Waiver and Release Agreement, in a form acceptable to the Plan Administrator, an Eligible Employee who terminates
employment on account of a Triggering Event shall be eligible to receive severance pay and severance benefits as described below and subject to the other provisions of this Plan. The consideration for the voluntary Waiver and Release Agreement shall
be the severance pay and severance benefits the Eligible Employee would not otherwise be eligible to receive. 

  
 7 

 5.2. Severance Pay. Severance pay shall be determined in accordance with the table
below based on the Eligible Employee’s “Tier” classification and in accordance with the terms hereof. If the applicable Triggering Event occurs on or within two (2) years following a Change in Control and the Eligible Employee
was an Employee at the time of the Change in Control, the Eligible Employee’s severance pay shall be determined under the column in the table below titled “Change in Control Severance Pay” and shall be paid in accordance with the
terms hereof. The Tier applicable to any Eligible Employee shall be determined by the Plan Administrator, in its sole discretion, based on the Eligible Employee’s job position relative to the job grading system in place for the applicable
Employer. 
  

					
	 Employment
Classification
	  	 Severance Pay not in connection

with a Change in Control
	  	 Change in Control Severance
Pay

	 Tier 1
 (Leadership
I)
	  	Fifty-two (52) Weeks of Pay plus an amount equal to the Eligible Employee’s Target Bonus.	  	Seventy-eight (78) Weeks of Pay plus an amount equal to 150% of the Eligible Employee’s Target Bonus.
			
	 Tier 2
 (Leadership
II)
	  	Fifty-two (52) Weeks of Pay.	  	Seventy-eight (78) Weeks of Pay.
			
	 Tier 3

(Management)
	  	Greater of (i) twenty-six (26) Weeks of Pay or (ii) two (2) Weeks of Pay for each Year of Service, limited to a maximum period of fifty-two (52) Weeks of Pay.	  	Same as severance pay not in connection with a Change in Control
			
	Tier 4	  	Greater of (i) fifteen (15) Weeks of Pay or (ii) two (2) Weeks of Pay for each Year of Service, limited to a maximum period of thirty-nine (39) Weeks of Pay.	  	Same as severance pay not in connection with a Change in Control
			
	Tier 5	  	Greater of (i) nine (9) Weeks of Pay or (ii) two (2) Weeks of Pay for each Year of Service, limited to a maximum period of twenty-six (26) Weeks of Pay.	  	Same as severance pay not in connection with a Change in Control

 Severance pay shall be paid in a lump sum payment within seventy-five (75) days following the
Severance Date. Notwithstanding the foregoing, any severance pay and severance benefits which become payable shall be paid only if the Eligible Employee has executed and not revoked a signed Waiver and Release Agreement prior to the payment. All
legally required taxes and any sums owed the Employer shall be deducted from Plan severance pay. 
 If an Employer reemploys an
Eligible Employee who is receiving or has received severance pay and benefits under the Plan, the individual shall become ineligible and such pay 

  
 8 

 
and benefits shall cease effective as of the reemployment date. Further, the former Eligible Employee must repay the portion of the severance pay attributable to the period that begins on the
date the Eligible Employee was reemployed. If the Plan Administrator, in its sole discretion, determines that the former Eligible Employee’s services address a critical business need, then the Plan Administrator may provide that no such
repayment is required. 
 5.3. Severance Benefits. 

(a) Medical, Dental and Vision Benefits Coverage Continuation. Under federal health care continuation coverage law (referred to as
“COBRA”), the Eligible Employee who is receiving health care coverage under an employer-sponsored plan is entitled to elect health care continuation coverage under the applicable health plan for the Eligible Employee and his/her
eligible dependents if his/her employment terminates for certain reasons. Any of the Triggering Events would qualify the Eligible Employee to receive such continuation coverage, subject to the terms of the applicable health plan and governing law.
If an Eligible Employee experiences a Triggering Event before his/her WARN Notice Period (if applicable) expires, his/her COBRA rights begin when the WARN Notice Period expires. 

If an Eligible Employee elects to exercise his/her applicable COBRA continuation rights under the health plan(s) in which the Eligible
Employee participated while employed by the Employer, for the lesser of six (6) months or the applicable Benefit Continuation Period (as defined below), the Eligible Employee will only be required to pay the same share of the applicable premium
that would apply if he/she were participating in the applicable health plan(s) as an active employee. For the balance of the Benefit Continuation Period, if any, the Eligible Employee will be required to pay the full monthly COBRA premium and, on a
monthly basis, the Employer will reimburse the Eligible Employee for the full cost of the COBRA premiums paid, less the amount that would apply if he/she were participating in the applicable health plan(s) as an active employee. For purposes of the
Plan, “Benefit Continuation Period” shall mean for Eligible Employees in Tiers 1 and 2, twelve (12) months, and for Eligible Employees in Tiers 3 through 5, the period of time following the Severance Date in which the Eligible
Employee is entitled to receive regular severance pay not in connection with a Change in Control under the Plan (regardless of whether the Eligible Employee is entitled to Change in Control severance pay) not to exceed six (6) months. Any
partial month will be rounded up to the next whole month. Notwithstanding anything herein to the contrary, the Benefit Continuation Period shall cease prior to the end of the periods set forth above on the earlier to occur of (i) the date that
the terminated Eligible Employee and/or his/her covered dependents, as applicable, are no longer eligible for COBRA or (ii) the date that the terminated Eligible Employee becomes eligible for new healthcare coverage (other than through the
Eligible Employee’s spouse). The Eligible Employee shall notify the Employer within ten (10) days following the date on which the Employee becomes eligible for new healthcare coverage. 

All of the terms and conditions of the health plan(s) in which the Eligible Employee participated while employed by the Employer, for
medical, dental and vision benefits, as amended from time to time, shall be applicable to an Eligible Employee (and his/her eligible dependents, if applicable) participating in any form of continuation coverage under the applicable medical, dental
and vision benefit plans. This Plan is not to be interpreted to expand an Eligible Employee’s health care continuation rights under COBRA. 

  
 9 

 (b) Career Transition Assistance. A career transition assistance firm selected and
paid for by an Employer shall provide career transition assistance. An Eligible Employee must begin the available career transition assistance services within sixty (60) days following his/her Severance Date. 

Subject to the limitations set forth above, career transition assistance shall be provided for the periods set forth below in the
following table, with such periods commencing from the inception of the services: 
  

					
	 Employment
 Classification
	  	Career Transition Services	 
	 Tier 1
	  	 	12 months	  
	 Tier 2
	  	 	12 months	  
	 Tier 3
	  	 	9 months	  
	 Tier 4
	  	 	6 months	  
	 Tier 5
	  	 	1 month	  

 5.4. Taxes. If any payment or benefit the Eligible Employee would receive pursuant
to this Plan (“Payment”) would (a) constitute a “Parachute Payment” within the meaning of Code Section 280G, and (b) but for this sentence, be subject to the excise tax imposed by Code Section 4999 (the
“Excise Tax”), then such Payment shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to
the Excise Tax or (y) the largest portion, up to and including the total of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the
highest applicable marginal rate), results in the Eligible Employee’s receipt, on an after-tax basis, of the greatest economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in
payments or benefits constituting Parachute Payments is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the manner that results in the greatest economic benefit for the Eligible Employee. If more than one method of
reduction will result in the same economic benefit, the items so reduced will be reduced pro rata.  

ARTICLE VI 
 WAIVER AND RELEASE AGREEMENT 
 In order to receive the severance pay and severance benefits available under the Plan, an Eligible Employee must submit a signed Waiver and Release Agreement form to the Plan Administrator on or within
forty-five (45) days after his/her Severance Date or receipt of the Waiver and Release Agreement, whichever occurs later. The required Waiver and Release Agreement form is attached to the Summary Plan Description as Attachment III, as the same
may be changed in the Company’s sole discretion. An Eligible Employee may revoke his/her 

  
 10 

 
signed Waiver and Release Agreement within seven (7) days of his/her signing the Waiver and Release Agreement. Only with respect to Eligible Employees whose severance under the Plan is
“non-qualified deferred compensation” subject to Section 409A of the Code, notwithstanding any provision of this Plan to the contrary, in no event shall the timing of such Eligible Employee’s execution of the Waiver and Release
Agreement, directly or indirectly, result in the Eligible Employee designating the calendar year of payment, and if a payment that is subject to execution of the Waiver and Release Agreement could be made in more than one taxable year, payment shall
be made in the later taxable year. 
 Any such revocation must be made in writing and must be received by the Plan Administrator
within such seven-(7) day period. An Eligible Employee who timely revokes his/her Waiver and Release Agreement shall not be eligible to receive any severance pay or severance benefits under the Plan. An Eligible Employee who timely submits
a signed Waiver and Release Agreement form and who does not exercise his/her right of revocation shall be eligible to receive severance pay and severance benefits under the Plan. 

Eligible Employees shall be advised to contact their personal attorney at their own expense to review the Waiver and Release Agreement
form if they so desire. 
 ARTICLE VII 
 PLAN ADMINISTRATION 
 The Company shall
designate a committee to serve as the “Plan Administrator” of the Plan and the “named fiduciary” within the meaning of such terms as defined in ERISA. The Plan Administrator shall have full power and discretionary authority to
determine eligibility for Plan severance pay and severance benefits and to construe the terms of the Plan, including, but not limited to, the making of factual determinations, the determination of all questions concerning benefits and procedures for
claim review and the resolution of all other questions arising under the Plan. Severance pay and severance benefits under the Plan will be payable only if the Plan Administrator determines in the Plan Administrator’s discretion that the
Eligible Employee is entitled to them. The decisions of the Plan Administrator shall be final and conclusive with respect to all questions concerning the administration of this Plan. 

The Plan Administrator may delegate to other persons responsibilities for performing certain of the duties of the Plan Administrator
under the terms of this Plan and may seek such expert advice as the Plan Administrator deems reasonably necessary with respect to the Plan. The Plan Administrator shall be entitled to rely upon the information and advice furnished by such delegatees
and experts, unless actually knowing such information and advice to be inaccurate or unlawful. The Plan Administrator shall establish and maintain a reasonable claims procedure, including a procedure for appeal of denied claims. The Plan
Administrator has discretionary authority to grant or deny benefits under this Plan. In no event shall an Eligible Employee or any other person be entitled to challenge a decision of the Plan Administrator in court or in any other administrative
proceeding unless and until the claim and appeals procedures established under this Plan have been complied with and exhausted. 

  
 11 

 In the event of a group termination, as determined in the sole discretion of the Plan
Administrator, the Plan Administrator shall furnish affected Eligible Employees with such additional information as may be required by law. 
 ARTICLE VIII 
 PROCEDURES FOR
MAKING AND APPEALING 
 CLAIMS FOR
PLAN BENEFITS 
 8.1. Claim for Benefits. It is not necessary that an Eligible Employee
apply for severance pay and severance benefits under the Plan. However, if an Eligible Employee wishes to file a claim for severance pay and severance benefits, such claim must be in writing and filed with the Plan Administrator. If the Eligible
Employee does not provide all the necessary information for the Plan Administrator to process the claim, the Plan Administrator may request additional information and set deadlines for the Eligible Employee to provide that information. Within ninety
(90) days after receiving a claim, the Plan Administrator will: 
  

	 	(a)	either accept or deny the claim completely or partially; and 

  

	 	(b)	notify the claimant of acceptance or denial of the claim. 

 8.2. Benefits Review. If the claim is completely or partially denied, the Plan Administrator will furnish a written notice to the claimant containing the following information: 

 

	 	(a)	specific reasons for the denial; 

  

	 	(b)	specific references to the Plan provisions on which any denial is based; 

  

	 	(c)	a description of any additional material or information that must be provided by the claimant in order to support the claim and an explanation of why such material or
information is necessary; and 

  

	 	(d)	an explanation of the Plan’s appeal procedures which shall also include a statement of the claimant’s right to bring a civil action under Section 502(a)
of ERISA following a denial of the claim upon review. 

 8.3. Appeal of Denied Claim. A claimant may appeal
the denial of his/her claim and have the Plan Administrator reconsider the decision. The claimant or the claimant’s authorized representative has the right to: 
  

	 	(a)	request an appeal by written request to the Plan Administrator not later than sixty (60) days after receipt of notice from the Plan Administrator denying his
claim; 

  

	 	(b)	review or receive copies, upon request and free of charge, any documents, records or other information “relevant” (within the meaning of Department of Labor
Regulation 2560.503-1(m)(8)) to the claimant’s claim; and 

  
 12 

	 	(c)	submit written comments, documents, records and other information relating to his/her claim. 

In deciding a claimant’s appeal the Plan Administrator shall take into account all comments, documents, records and other
information submitted by the claimant relating to the claim, without regard to whether such information was submitted or considered in the initial review of the claim. If the claimant does not provide all the necessary information for the Plan
Administrator to decide the appeal, the Plan Administrator may request additional information and set deadlines for the claimant to provide that information. 
 The Plan Administrator will make a decision with respect to such an appeal within sixty (60) days after receiving the written request for such appeal or, in special circumstances, within one-hundred
twenty (120) days after receiving the written request for such appeal. The claimant will be advised of the Plan Administrator’s decision on the appeal in writing. The notice will set forth (1) the specific reasons for the decision,
(2) specific reference to Plan provisions upon which the decision on the appeal is based, (3) a statement that the claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents,
records or other information relevant to the claimant’s claim, and (4) a statement of the claimant’s right to bring a civil action under Section 502(a) of ERISA following a wholly or partially denied claim for benefits.

 In no event shall a claimant or any other person be entitled to challenge a decision of the Plan Administrator in court or in
any other administrative proceeding unless and until the claim and appeal procedures described above have been complied with and exhausted. 
 ARTICLE IX 

AMENDMENT/TERMINATION/VESTING 

Eligible Employees do not have any vested right to severance pay and/or severance benefits under the Plan and the Company reserves the
right, in its sole discretion, to amend or terminate the Plan at any time in writing, signed by an authorized officer of the Company, provided, however, that (i) no amendment nor termination shall reduce severance pay or severance benefits
attributable to a Triggering Event that occurs prior to the date the Plan is amended or terminates, and (ii) any amendment or termination that becomes effective after a Change in Control shall not adversely affect the rights of any Eligible
Employee compared with such Eligible Employee’s rights if his/her employment terminated effective immediately before such amendment or termination became effective. 
 The Plan shall be effective only with respect to Triggering Events that occur on or before December 31, 2015. The Company may extend the Plan in its sole discretion. 

ARTICLE X 
 NO ASSIGNMENT 
 Severance pay and severance
benefits payable under the Plan shall not be subject to anticipation, alienation, pledge, sale, transfer, assignment, garnishment, attachment, execution, encumbrance, levy, lien, or charge, and any attempt to cause such severance pay and severance
benefits to be so subjected shall not be recognized, except to the extent required by law. 

  
 13 

 ARTICLE XI 

CONFIDENTIAL INFORMATION/COOPERATION 

Recognizing that the disclosure or improper use of Confidential Information will cause serious and irreparable injury to an Employer,
Eligible Employees with such access acknowledge that (i) they will not at any time, directly or indirectly, disclose Confidential Information to any third party or otherwise use such Confidential Information for their own benefit or the benefit
of others and (ii) in addition to any other remedy permissible by law, payment of severance pay and severance benefits under the Plan shall cease if an Eligible Employee discloses or improperly uses such Confidential Information. Any Eligible
Employee subject to an individual confidentiality agreement or proprietary rights agreement with an Employer or any Affiliate will be deemed to violate the terms of this Article XI if he/she violates the terms of the individual confidentiality
agreement or proprietary rights agreement. 
 Subject to the terms of the Waiver and Release Agreement, each Eligible Employee
shall cooperate with any Employer and its legal counsel in connection with any current or future investigation or litigation relating to any matter to which the Eligible Employee was involved or of which the Eligible Employee has knowledge or
which occurred during the Eligible Employee’s employment. Such assistance shall include, but not be limited to, depositions and testimony and shall continue until such matters are resolved. In addition, an Eligible Employee shall not in any way
disparage any Employer nor any person associated with an Employer to any person, corporation, or other entity. 
 ARTICLE
XII 
 MISCELLANEOUS PROVISIONS 

12.1. Return of Property. In order for an Eligible Employee to commence receiving severance pay and severance benefits under the
Plan, (i) he/she shall be required to return all Employer property (including, but not limited to, Confidential Information, client lists, keys, credit cards, documents and records, identification cards, equipment, laptop computers, software,
and pagers), and (ii) repay any outstanding bills, advances, debts, amounts due to an Employer, as of his/her Severance Date. To the extent the Eligible Employee has any Employer property stored electronically (including, but not limited to, in
the form of email) on his/her personal computer, in a personal email account, on a personal storage device, or otherwise, such Eligible Employee shall promptly provide copies of all such information to the Employer and thereafter permanently delete
or otherwise destroy the Eligible Employee’s personal copy. 
 All pay and other benefits (except Plan severance pay and
severance benefits) payable to an Eligible Employee as of his/her Severance Date according to the established policies, plans, and procedures of the Employer shall be paid in accordance with the terms of those established policies, plans and
procedures. In addition, any benefit continuation or conversion rights which an Eligible Employee has as of his/her Severance Date according to the established policies, plans, and procedures of the Employer shall be made available to him/her.

  
 14 

 12.2. Code Section 409A Compliance. It is the Company’s intent that amounts
paid under this Plan shall not constitute “deferred compensation” as that term is defined under Code Section 409A and the regulations promulgated thereunder because the amounts paid under this Plan are structured to comply with the
“short-term deferral” exception to Code Section 409A. However, if any amount paid under this Plan is determined to be “deferred compensation” within the meaning of Code Section 409A and compliance with one or more of
the provisions of this Plan causes or results in a violation of Code Section 409A, then such provision shall be interpreted or reformed in the manner necessary to achieve compliance with Code Section 409A, including but not limited to, the
imposition of a six (6) month delay in payment to any “specified employee” (as defined in Code Section 409A) following such specified employee’s date of termination which entitles him/her to a payment under this Plan. All
payments to be made upon a termination of employment under this Plan may only be made upon a “separation from service” under Code Section 409A. In no event may the Eligible Employee, directly or indirectly, designate the calendar year
of a payment. 
 12.3. Representations Contrary To The Plan. No employee, officer, or director of an Employer has the
authority to alter, vary, or modify the terms of the Plan except by means of an authorized written amendment to the Plan. No verbal or written representations contrary to the terms of the Plan and its written amendments shall be binding upon the
Plan, the Plan Administrator, or an Employer. 
 12.4. No Employment Rights. This Plan shall not confer employment rights
upon any person. No person shall be entitled, by virtue of the Plan, to remain in the employ of an Employer and nothing in the Plan shall restrict the right of an Employer to terminate the employment of any Eligible Employee or other person at
any time. 
 12.5. Plan Funding. No Eligible Employee shall acquire by reason of the Plan any right in or title to any
assets, funds, or property of the Employer. Any severance pay, which becomes payable under the Plan is an unfunded obligation and shall be paid from the general assets of the Company. No employee, officer, director or agent of the Employer
personally guarantees in any manner the payment of Plan severance pay and severance benefits. 
 12.6. Applicable Law.
This Plan shall be governed and construed in accordance with ERISA and in the event that any reference shall be made to State law, the laws of the State of Delaware shall apply, without regard to its conflicts of law provisions. 

12.7. Severability. If any provision of the Plan is found, held or deemed by a court of competent jurisdiction to be void,
unlawful or unenforceable under any applicable statute or other controlling law, the remainder of the Plan shall continue in full force and effect. 
 12.8. Recovery Of Payments Made By Mistake. An Eligible Employee shall be required to return to the Company any severance pay payment and any severance benefits payment, or portion thereof, made by
a mistake, including but not limited to, any mistake of fact or law. 
  
  

			
	PROTHENA BIOSCIENCES INC
		
	By:	 	/s/ Dale B. Schenk
		
	Its:	 	President and Chief Executive Officer

  
 15 

 PROTHENA BIOSCIENCES INC 

SEVERANCE PLAN 
 ATTACHMENT A 
 For purposes of this Plan, “Employer” means
Prothena Biosciences Inc and each of the following Affiliates to the extent each remains an Affiliate (including wholly-owned subsidiaries of these Affiliates): None.EX-10.18

 Exhibit 10.18 
 Prothena Biosciences Inc 
 REVISED –
December 21, 2012 
 Dear Gene: 
 Further to your Letter of Intent for Neotope Employment (dated September 26, 2012), I am pleased to confirm this offer to join Prothena Biosciences Inc1 (“Prothena” or the “Company”), commencing on the
day following the closing date of the demerger (the “Transaction”) of the Company (and its affiliates) from Elan Corporation, plc – which occurred on December 20, 2012. 
 We are confident in your knowledge, expertise and judgment, and believe your performance will meet the high-quality objectives and standards set by Prothena leadership and management. You will be employed
as Chief Scientific Officer and Head of Research & Development, reporting to me, although your duties and title may change, based on the Company’s needs and priorities. This is a full-time, exempt position. 

Your original date of hire with Elan and its subsidiaries will remain as your original date of hire within Prothena’s programs relating to
employment, compensation and employee benefit plans. 
 Your starting salary will be $340,000.00 annually, paid twice per month. Your pay
is subject to applicable taxes and withholdings. 
 Prothena embraces a pay-for-performance philosophy. All employees are currently eligible for
an annual cash bonus under the terms of the Company’s cash incentive plan (Prothena Biosciences Inc Incentive Compensation Plan). Cash incentive awards are determined by a number of factors, including industry competitiveness, Prothena’s
business strategy, and the degree to which Company, function and/or individual goals are met. The target bonus opportunity for your position is currently 40% of plan year salaried-earnings. A condition to earning a cash incentive award is
that an employee remains employed through the pay date of the award, which will be not later than March 15 in the year following the conclusion of the plan year. The cash bonus plan is operated at the sole discretion of Prothena, is subject to
review on a regular basis and may change from time to time. 
 You will be eligible to receive an equity award of
200,0002 stock options in connection with your
commencement of employment following the Transaction. This award is at the discretion of the Prothena Board of Directors and is subject to its approval, the terms of the Company’s equity incentive plan (Prothena Corporation plc 2012 Long
Term Incentive Plan), and the Company’s standard equity award agreement. The Exercise Price will be set as the average of the closing price of Prothena’s ordinary shares for the first 25 trading days commencing on the first day of trading
on the NASDAQ Global Market listing. The Grant Date will be the 25th trading
day.3 The award will vest 25% after the first year of
active service from the Grant Date, and monthly at a rate of 1/48th of the award thereafter, such that the award will fully vest after a four-year period of continuous employment. 
 On the first day of the month following your Start Date of employment, you will be eligible to participate in Prothena’s comprehensive benefits program, including the company’s health and
welfare and retirement benefit plans. Details about these and other applicable plans will be provided separately, as will further information regarding certain onboarding items and other documents needed before your Start Date (e.g., direct deposit
election, W-4 allowances, Employee Proprietary Information and Invention Assignment Agreement). 
  

	1 	The legal entity Neotope Biosciences, Inc. was renamed Prothena Biosciences Inc on November 1, 2012 

	2 	This represents slightly more than 1.10% of Prothena’s expected common shares outstanding post Transaction. 

	3 	Assumes approval on Start Date by Prothena’s Board of Directors; should approval occur at a later date, the 25-day period would start on the date of approval.

 Prothena Biosciences Inc 
 Your employment is “at will.” This means that you or Prothena each has the right to terminate the employment relationship at any time, with or without cause. Nothing in this letter should be
taken as a guarantee of continued employment or a specific term of employment. Further, all benefits and compensation provided by the Company are contingent upon your continued employment. 
 To accept our offer, please sign this letter and return to Kevin Hickey. By signing this letter, you acknowledge that it sets out our entire agreement between the parties and supersedes all prior oral and
written agreements, understandings, commitments and practices between the parties, including the Letter of Intent for Neotope Employment dated September 26, 2012. No amendments to this agreement may be made except in writing signed by a
duly authorized representative of Prothena. 
 We look forward to having you join Prothena. If you have any questions, or would like additional
information to help you reach a decision, please feel free to contact Kevin at (650) 278-1762. 
 Sincerely, 

/s/ Dale Schenk 
 Dale Schenk 

President and CEO 
 Prothena Biosciences Inc

 ACCEPTANCE: 
  

					
			
	/s/ Gene Kinney	 		 	12/22/2012
	Gene Kinney	 		 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}]]